NCT06903910View on ClinicalTrials.gov

Investigating the Cholinergic Contribution to Gait Dysfunction in Parkinson's Disease

PHASE2RecruitingINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

September 30, 2025

Conditions
Parkinson Disease
Interventions
DRUG

Donepezil (Aricept)

Donepezil is a cholinesterase inhibitor tablet taken by mouth once nightly

Trial Locations (1)

22903

RECRUITING

University of Virginia, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER